Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis
- 26 February 2008
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 27 (7), 565-570
- https://doi.org/10.1007/s10096-008-0475-9
Abstract
In vitro, ciprofloxacin can select for dual resistance to fluoroquinolones and imipenem in Pseudomonas aeruginosa via a mutation in the regulatory gene, mexT, which downregulates OprD and upregulates MexEF-OprN. We performed a nested case-control study of patients in two medical intensive care units participating in an observational cohort study. Patients colonized or infected with P. aeruginosa resistant to both ciprofloxacin and imipenem (cases) were compared to controls. The presence of OprD and OprN from cases was evaluated by Western blot. In total, 44 cases were compared to 132 controls. Imipenem exposure [adjusted odds ratio (AOR) = 11.4, p = 0.044] was significantly associated with case status, but fluoroquinolone use was not (AOR = 1.0, p = 0.998). Neither OprD nor OprN were detected in any isolate. Fluoroquinolone use was not a risk factor for acquisitions of dually resistant P. aeruginosa. The absence of OprN in these isolates suggests that dual resistance is not due to mexT mutations.Keywords
This publication has 24 references indexed in Scilit:
- Potency of Carbapenems for the Prevention of Carbapenem-Resistant Mutants of Pseudomonas aeruginosaThe Journal of Antibiotics, 2006
- Effects of an Antibiotic Cycling Program on Antibiotic Prescribing Practices in an Intensive Care UnitAntimicrobial Agents and Chemotherapy, 2004
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002
- Non-touch fittings in hospitals: a possible source of Pseudomonas aeruginosa and Legionella spp.Journal of Hospital Infection, 2001
- Variation of the mexT gene, a regulator of the MexEF-OprN efflux pump expression in wild-type strains of Pseudomonas aeruginosaFEMS Microbiology Letters, 2000
- Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998Drugs, 1999
- Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosaMolecular Microbiology, 1997
- The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivoJournal of Antimicrobial Chemotherapy, 1987
- Emergence of Resistance to Imipenem During Therapy for Pseudomonas aeruginosa InfectionsThe Journal of Infectious Diseases, 1986
- APACHE IICritical Care Medicine, 1985